Chat with us, powered by LiveChat

Loading...
Airway Management Devices Market, By Type

RA00081

Airway Management Devices Market, By Type (Infraglottic Airway Management Devices, Supraglottic Airway Management Devices, Resuscitators, Laryngoscopes, Others), By End-use (Operating Rooms, Emergency Care, Departments, Intensive Care Units, Others), By Patient Age (Adult Patient, Pediatric Patient): Global Opportunity Analysis and Industry Forecast, 2019–2026

RA00081

Pages: 170

Feb 2020

Global Airways Management Devices Market Insights 2026:

Global Airway management devices market forecast will be $2,178.8 million by 2026, rising from $ 1,230.8 million in 2018, at a CAGR of 7.4%. The North America region accounted for the largest share in 2018, accounting for over $504.6 million and this will grow at 7.1% CAGR.

Rising occurrences of chronic respiratory diseases globally is the key growth factor that is anticipated to drive the market growth over the forecast period. As per the survey conducted by World Health Organization (WHO), about 90% of the deaths occur due to Chronic Obstructive Pulmonary Diseases (COPD); this is majorly observed in underdeveloped and developing economies. 

In spite of the wide range of advantages, major factors affecting the market growth are the economic barriers that are limiting the access for good health treatments, and lack of skilled professionals in developing economies are anticipated to hamper the Airway Management Devices Market growth.  

Airway Management Devices Market, by Type:

The Infraglottic Airway Management Devices segment is predicted to be most lucrative till the end of 2026

Airway Management Devices Market, by Type	 
Source: Research Dive Analysis

The infraglottic airway devices held the major Airway Management Devices Market share in 2018 of 32.8%, and accounted for $403.7 million in the year 2018 and is expected to grow at a CAGR of 6.4% over the forecast period. However, supraglottic airway management devices segment is anticipated to register the highest growth rate over the forecast period growing at a CAGR of 8.3%. The supraglottic airway devices is anticipated to witness foremost traction due to its lightweight properties combined with a rise in demand in aircraft applications.  In addition, growth in the demand for metal foam armors majorly for space-based vehicle and military aircrafts are likely to create significant market growth opportunities. 

Airway Management Devices Market, by Patient Age

Pediatric patient segment is predicted to be most lucrative till the end of 2026

Airway Management Devices Market, by Patient Age
Source: Research Dive Analysis

The adult patients segment held the largest market value in the year 2018, by accounting for $763.1 million. The growing adult population and the increase in the occurrence of chronic diseases in geriatric patients are the key factors contributing for the of adult patients age segment. Moreover, pediatric patients segment is anticipated to drive the global Airway Management Devices Market over the forecast period growing at CAGR of 8.1%, accounting for more than $869.3 million by 2026.

Airway Management Devices Market, by Mode of End-use

Emergency Care Departments segment is predicted to be most lucrative till the end of 2026
Airway Management Devices Market, by Mode of End-use	 

Source: Research Dive Analysis

The operating rooms in end-use segment held the largest market share in 2018 accounting for 38.90%. Operating room market valued for $478.8 million in 2018 and is anticipated to reach $823.6 million by 2026 growing at a CAGR of 7.0% over the forecast period. The major share of operating rooms segment is due to the, rising number of surgical processes that are being performed since they require airway management devices for oxygenation and ventilation.

Airway Management Devices Market, by Region:

Asia-Pacific Airway Management Devices Market will have enormous opportunities for the market investors to grow over the coming years.

North America airways management devices industry accounted for the largest market share in the year 2018 accounting for $ 504.6 million and is further anticipated to grow at a CAGR of 7.1% over the forecast period. On the other hand, the Asia-Pacific market is anticipated to experience a swift growth over the forecast period, majorly due to the growing adoption of airway management devices in developing nations such as, India, China, and South Korea.

To explore more about Airways Management Devices Market, get in touch with our analysts here https://www.researchdive.com/81/Analyst-Review/airway-management-devices-market

Key Participants in the Global Airway Management Devices Market:

Product development and joint ventures are the most common strategies followed by the market players

Key participants in the Global Airway Management Devices Market
Source: Research Dive Analysis

Airway management devices market players include Intersurgical, Smiths Medical, Teleflex, SunMed, Medtronic, Ambu A/S, KARL STORZ, Flexicare, Vyaire Medical and VBM Medizintechnik among many others. Product development and acquisitions are some of the key strategies opted by the industry participants to retain their position in the global or regional markets. These key players are majorly concentrating on technology advancements in current technology, new product launches, mergers and acquisitions, and geographical expansion. These are some of the growth strategies adopted by these companies.

In March 2017, Smiths Medical broadcasted about the launch of three innovative devices for airway management, blood pressure monitoring and ambulatory infusion. The airway management device namely “aerFree” has cleared FDA certifications for exteriors negative pressure support.

Aspect

Particulars

  Historical Market Estimations

  2018-2019

  Base Year for Market Estimation

  2018

  Forecast timeline for Market Projection

  2019-2026

  Geographical Scope

  North America, Europe, Asia-Pacific, LAMEA

  Segmentation by Type

  • Infraglottic Airway Management Devices

  • Supraglottic Airway Management Devices

  • Resuscitators

  • Laryngoscopes

  • Others

  Segmentation by Patient Age

  • Adult Patient

  • Pediatric Patient

  Segmentation by End-use

  • Operating Rooms

  • Emergency Care Departments

  • Intensive Care Units

  • Others

  Key Countries Covered

U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

  Key Companies Profiled

  • Medtronic

  • Smith Medical

  • Telflex

  • KARL STORZ SE & Co. KG

  • AMBU A/S.

  • Flexicare Medical Limited

  • Intersurgical Ltd

  • SunMed

  • VYAIRE MEDICAL, INC.

  • Vbm Medizintechnik

Source: Research Dive Analysis


FREQUENTLY ASKED QUESTIONS?
 

A. The global Airway Management Devices Market size was over $1,230.8 million in 2018, and is further anticipated to reach $2,178.8 million by 2026.

A. AMBU A/S, Medtronic, Teleflex and SunMed are some of the key players in the global Airway Management Devices Market.

A. Asia-Pacific possesses great investment opportunities for the investors to witness the most promising growth in the coming years.

A. Asia-Pacific Airway Management Devices Market is projected to grow at 7.8% CAGR during the forecast period.

A. Product development and joint ventures are the key strategies opted by the operating companies in this market.

A. Medtronic and Smiths Medical are investing more in R&D activities for developing new products and technologies.

1. Research Methodology

1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters

1.4.1. Assumptions
1.4.2. Forecast parameters

1.5. Data sources

1.5.1. Primary
1.5.2. Secondary

2. Executive Summary

2.1. 360° summary
2.2. Type trends
2.3. Patient Age trends
2.4. End-use trends

3. Market Overview

3.1. Market segmentation & definitions
3.2. key takeaways

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market

3.4. Market dynamics

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

3.5. Patient Age landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Market value chain analysis
3.9. Strategic overview

4. Airway Management Devices Market, by Type

4.1. Infraglottic Airway Management Devices

4.1.1. Market size and forecast, by region, 2016-2026
4.1.2. Comparative market share analysis, 2018 & 2026

4.2. Supraglottic Airway Management Devices

4.2.1. Market size and forecast, by region, 2016-2026
4.2.2. Comparative market share analysis, 2018 & 2026

4.3. Resuscitators

4.3.1. Market size and forecast, by region, 2016-2026
4.3.2. Comparative market share analysis, 2018 & 2026

4.4. Laryngoscopes

4.4.1. Market size and forecast, by region, 2016-2026
4.4.2. Comparative market share analysis, 2018 & 2026

4.5. Others

4.5.1. Market size and forecast, by region, 2016-2026
4.5.2. Comparative market share analysis, 2018 & 2026

5. Airway Management Devices Market, by Patient Age

5.1. Adult Patient

5.1.1. Market size and forecast, by region, 2016-2026
5.1.2. Comparative market share analysis, 2018 & 2026

5.2. Pediatric Patient

5.2.1. Market size and forecast, by region, 2016-2026
5.2.2. Comparative market share analysis, 2018 & 2026

6. Airway Management Devices Market, by End-use

6.1. Operating Rooms

6.1.1. Market size and forecast, by region, 2016-2026
6.1.2. Comparative market share analysis, 2018 & 2026

6.2. Emergency Care Departments

6.2.1. Market size and forecast, by region, 2016-2026
6.2.2. Comparative market share analysis, 2018 & 2026

6.3. Intensive Care Units

6.3.1. Market size and forecast, by region, 2016-2026
6.3.2. Comparative market share analysis, 2018 & 2026

6.4. Others

6.4.1. Market size and forecast, by region, 2016-2026
6.4.2. Comparative market share analysis, 2018 & 2026 

7. Airway Management Devices Market, by Region

7.1. North America

7.1.1. Market size and forecast, by Type, 2016-2026
7.1.2. Market size and forecast, by Patient Age, 2016-2026
7.1.3. Market size and forecast, by end-use, 2016-2026
7.1.4. Market size and forecast, by country, 2016-2026
7.1.5. Comparative market share analysis, 2018 & 2026
7.1.6. U.S.

7.1.6.1. Market size and forecast, by Type, 2016-2026
7.1.6.2. Market size and forecast, by Patient Age, 2016-2026
7.1.6.3. Market size and forecast, by end-use, 2016-2026
7.1.6.4. Comparative market share analysis, 2018 & 2026

7.1.7. Canada

7.1.7.1. Market size and forecast, by Type, 2016-2026
7.1.7.2. Market size and forecast, by Patient Age, 2016-2026
7.1.7.3. Market size and forecast, by end-use, 2016-2026
7.1.7.4. Comparative market share analysis, 2018 & 2026

7.1.8. Mexico

7.1.8.1. Market size and forecast, by Type, 2016-2026
7.1.8.2. Market size and forecast, by Patient Age, 2016-2026
7.1.8.3. Market size and forecast, by end-use, 2016-2026
7.1.8.4. Comparative market share analysis, 2018 & 2026

7.2. Europe

7.2.1. Market size and forecast, by Type, 2016-2026
7.2.2. Market size and forecast, by Patient Age, 2016-2026
7.2.3. Market size and forecast, by end-use, 2016-2026
7.2.4. Market size and forecast, by country, 2016-2026
7.2.5. Comparative market share analysis, 2018 & 2026
7.2.6. UK

7.2.6.1. Market size and forecast, by Type, 2016-2026
7.2.6.2. Market size and forecast, by Patient Age, 2016-2026
7.2.6.3. Market size and forecast, by end-use, 2016-2026
7.2.6.4. Comparative market share analysis, 2018 & 2026

7.2.7. Germany

7.2.7.1. Market size and forecast, by Type, 2016-2026
7.2.7.2. Market size and forecast, by Patient Age, 2016-2026
7.2.7.3. Market size and forecast, by end-use, 2016-2026
7.2.7.4. Comparative market share analysis, 2018 & 2026

7.2.8. France

7.2.8.1. Market size and forecast, by Type, 2016-2026
7.2.8.2. Market size and forecast, by Patient Age, 2016-2026
7.2.8.3. Market size and forecast, by end-use, 2016-2026
7.2.8.4. Comparative market share analysis, 2018 & 2026

7.2.9. Spain

7.2.9.1. Market size and forecast, by Type, 2016-2026
7.2.9.2. Market size and forecast, by Patient Age, 2016-2026
7.2.9.3. Market size and forecast, by end-use, 2016-2026
7.2.9.4. Comparative market share analysis, 2018 & 2026

7.2.10. Italy

7.2.10.1. Market size and forecast, by Type, 2016-2026
7.2.10.2. Market size and forecast, by Patient Age, 2016-2026
7.2.10.3. Market size and forecast, by end-use, 2016-2026
7.2.10.4. Comparative market share analysis, 2018 & 2026

7.2.11. Rest of Europe

7.2.11.1. Market size and forecast, by Type, 2016-2026
7.2.11.2. Market size and forecast, by Patient Age, 2016-2026
7.2.11.3. Market size and forecast, by end-use, 2016-2026
7.2.11.4. Comparative market share analysis, 2018 & 2026 

7.3. Asia-Pacific

7.3.1. Market size and forecast, by Type, 2016-2026
7.3.2. Market size and forecast, by Patient Age, 2016-2026
7.3.3. Market size and forecast, by end-use, 2016-2026
7.3.4. Market size and forecast, by country, 2016-2026
7.3.5. Comparative market share analysis, 2018 & 2026

7.3.6. China

7.3.6.1. Market size and forecast, by Type, 2016-2026
7.3.6.2. Market size and forecast, by Patient Age, 2016-2026
7.3.6.3. Market size and forecast, by end-use, 2016-2026
7.3.6.4. Comparative market share analysis, 2018 & 2026

7.3.7. Japan

7.3.7.1. Market size and forecast, by Type, 2016-2026
7.3.7.2. Market size and forecast, by Patient Age, 2016-2026
7.3.7.3. Market size and forecast, by end-use, 2016-2026
7.3.7.4. Comparative market share analysis, 2018 & 2026

7.3.8. India

7.3.8.1. Market size and forecast, by Type, 2016-2026
7.3.8.2. Market size and forecast, by Patient Age, 2016-2026
7.3.8.3. Market size and forecast, by end-use, 2016-2026
7.3.8.4. Comparative market share analysis, 2018 & 2026

7.3.9. Australia

7.3.9.1. Market size and forecast, by Type, 2016-2026
7.3.9.2. Market size and forecast, by Patient Age, 2016-2026
7.3.9.3. Market size and forecast, by end-use, 2016-2026
7.3.9.4. Comparative market share analysis, 2018 & 2026

7.3.10. South Korea

7.3.10.1. Market size and forecast, by Type, 2016-2026
7.3.10.2. Market size and forecast, by Patient Age, 2016-2026
7.3.10.3. Market size and forecast, by end-use, 2016-2026
7.3.10.4. Comparative market share analysis, 2018 & 2026

7.3.11. Rest of Asia-Pacific

7.3.11.1. Market size and forecast, by Type, 2016-2026
7.3.11.2. Market size and forecast, by Patient Age, 2016-2026
7.3.11.3. Market size and forecast, by end-use, 2016-2026
7.3.11.4. Comparative market share analysis, 2018 & 2026

7.4. LAMEA

7.4.1. Market size and forecast, by Type, 2016-2026
7.4.2. Market size and forecast, by Patient Age, 2016-2026
7.4.3. Market size and forecast, by end-use, 2016-2026
7.4.4. Market size and forecast, by country, 2016-2026
7.4.5. Comparative market share analysis, 2018 & 2026
7.4.6. Brazil
7.4.7. Market size and forecast, by Type, 2016-2026
7.4.8. Market size and forecast, by Patient Age, 2016-2026
7.4.9. Market size and forecast, by end-use, 2016-2026
7.4.10. Comparative market share analysis, 2018 & 2026
7.4.11. Saudi Arabia

7.4.11.1. Market size and forecast, by Type, 2016-2026
7.4.11.2. Market size and forecast, by Patient Age, 2016-2026
7.4.11.3. Market size and forecast, by end-use, 2016-2026
7.4.11.4. Comparative market share analysis, 2018 & 2026

7.4.12. South Africa

7.4.12.1. Market size and forecast, by Type, 2016-2026
7.4.12.2. Market size and forecast, by Patient Age, 2016-2026
7.4.12.3. Market size and forecast, by end-use, 2016-2026
7.4.12.4. Comparative market share analysis, 2018 & 2026

7.4.13. Rest of LAMEA

7.4.13.1. Market size and forecast, by Type, 2016-2026
7.4.13.2. Market size and forecast, by Patient Age, 2016-2026
7.4.13.3. Market size and forecast, by end-use, 2016-2026
7.4.13.4. Comparative market share analysis, 2018 & 2026

8. Company Profiles

8.1. Medtronic 

8.1.1. Business overview
8.1.2. Financial performance
8.1.3. Type portfolio
8.1.4. Recent strategic moves & developments
8.1.5. SWOT analysis

8.2. Smiths Medical 

8.2.1. Business overview
8.2.2. Financial performance
8.2.3. Type portfolio
8.2.4. Recent strategic moves & developments
8.2.5. SWOT analysis

8.3. Teleflex 

8.3.1. Business overview
8.3.2. Financial performance
8.3.3. Type portfolio
8.3.4. Recent strategic moves & developments
8.3.5. SWOT analysis

8.4. KARL STORZ SE & Co. KG 

8.4.1. Business overview
8.4.2. Financial performance
8.4.3. Type portfolio
8.4.4. Recent strategic moves & developments
8.4.5. SWOT analysis

8.5. AMBU A/S.

8.5.1. Business overview
8.5.2. Financial performance
8.5.3. Type portfolio
8.5.4. Recent strategic moves & developments
8.5.5. SWOT analysis

8.6.  Flexicare Medical Limited 

8.6.1. Business overview
8.6.2. Financial performance
8.6.3. Type portfolio
8.6.4. Recent strategic moves & developments
8.6.5. SWOT analysis

8.7. Intersurgical Ltd 

8.7.1. Business overview
8.7.2. Financial performance
8.7.3. Type portfolio
8.7.4. Recent strategic moves & developments
8.7.5. SWOT analysis

8.8. SunMed 

8.8.1. Business overview
8.8.2. Financial performance
8.8.3. Type portfolio
8.8.4. Recent strategic moves & developments
8.8.5. SWOT analysis

8.9. VYAIRE MEDICAL, INC.

8.9.1. Business overview
8.9.2. Financial performance
8.9.3. Type portfolio
8.9.4. Recent strategic moves & developments
8.9.5. SWOT analysis

8.10. Vbm Medizintechnik 

8.10.1. Business overview
8.10.2. Financial performance
8.10.3. Type portfolio
8.10.4. Recent strategic moves & developments
8.10.5. SWOT analysis

In order to prevent or relieve any type of airway blockade, the medical experts use a set of maneuvers or medical techniques. The process is called airway management. The process is accomplished by either clearing a previously obstructed airway; or by preventing airway obstruction in cases such as the obtunded patient, anaphylaxis, or medical sedation.

The term ‘airway’ typically refers to the upper airway consisting of nasal and oral organs, larynx, pharynx, principle bronchi, and trachea. The primary causes of airway obstruction are foreign objects, tongue, the tissues of the airway itself, and pulmonary aspiration.

Basic and advanced are the two main categories of airway management techniques.

Basic techniques can be performed without any specialized medical equipment or advanced training and hence, non-invasive. Such techniques include head and neck maneuvers to optimize ventilation, back blows, and abdominal thrusts.

Advanced techniques, on the other hand, are performed with specialized medical training and equipment. Such categories are further bifurcated anatomically into supraglottic devices (such as nasopharyngeal and oropharyngeal airways), infraglottic techniques (such as tracheal intubation), and surgical methods (such as tracheotomy and ricothyrotomy).

Growth Drivers

Rising occurrence of chronic respiratory diseases across the globe is the key factor that is anticipated to boost the market growth during the upcoming period. According to a survey conducted by the World Health Organization (WHO), about 90% of the deaths are occurred due to Chronic Obstructive Pulmonary Diseases (COPD), this is majorly observed in under developed and developing economies.

As per Analyst Overview , the growth of the airway management devices market is driven mainly by the rising prevalence of chronic respiratory diseases, increasing demand for emergency care, high incidence of preterm births, growth in investments, funds, and grants by government bodies for improving emergency care infrastructure. Also, emerging economies such as China, India, Brazil, and Mexico are expected to offer lucrative growth opportunities for market players in the airway management devices market. 

On the contrary, factors such as the harmful effects of certain devices on neonates, the dearth of skilled professionals, and increasing pricing pressure on market players are adversely impacting the growth of the market.

The supraglottic airway devices is anticipated to witness foremost traction due to its lightweight properties combined with a rise in demand in aircraft applications. Additionally, growth in the demand for metal foam armors majorly for space-based vehicle and military aircrafts likely to create significant market growth opportunities .

The growing adult population and the increase in the occurrence of chronic diseases in geriatric patients are the key factors contributing for the of adult patients age segment.

Recent Developments

Product development and acquisitions are some of the key strategies opted by the industry participants to retain their position in the global or regional markets. These key players are majorly concentrating on technology advancements in current technology, new product launches, mergers and acquisitions, and geographical expansion. These are some of the growth strategies adopted by these companies.

In March 2017, Smiths Medical broadcasted about the launch of three innovative devices for airway management, blood pressure monitoring and ambulatory infusion. The airway management device namely “aerFree” has cleared FDA certifications for exteriors negative pressure support.
 

Purchase Options

Enquire To Buy

Personalize this research

  • Triangulate with your own data
  • Get Data as per your format and defination
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed